Agilus Diagnostics
 | |
| Formerly | SRL Limited[1] |
|---|---|
| Company type | Public |
| Industry | Diagnostics |
| Founded | 7 July 1995 |
| Headquarters | |
Number of locations | 418+ |
Area served | India, Dubai, Afghanistan and Nepal |
Key people | Anand Kuppuswamy (MD & CEO)[2] |
| Services | Pathology, Radiology |
| Revenue |  ₹1,605 crore (US$190 million) (FY22)[3] |
| ₹425 crore (US$51 million) (FY22)[3] | |
| Owners |
|
| Subsidiaries |
|
| Website | agilusdiagnostics |
Agilus Diagnostics Limited (formerly known as SRL Limited) is an Indian multinational diagnostics company providing diagnostic services in pathology and radiology. Agilus Diagnostics has its headquarters and corporate office in Gurgaon.
History
[edit]The company was founded in 1995 by brothers Shivinder Mohan Singh and Malvinder Mohan Singh as Specialty Ranbaxy Limited (SRL), a 50:50 joint venture between Ranbaxy Laboratories and US-based Specialty Laboratories.[5][6] It became the first pathology company in India to receive accreditation from National Accreditation Board.[7]
In 2001, SRL became a wholly-owned subsidiary of Ranbaxy Laboratories after Ranbaxy bought out Specialty Laboratories' stake; the company was subsequently renamed SRL Ranbaxy.[8]
In 2008, SRL Ranbaxy was renamed as Super Religare Laboratories.[9]
In 2010, Super Religare Laboratories acquired Piramal Diagnostic Services and its network of 107 laboratories from Piramal Healthcare for ₹600 crore.[10]
In 2011, Fortis Healthcare completed the acquisition of 74.59% stake in Super Religare Laboratories.[11] After being acquired by Fortis, the company rebranded itself as SRL Diagnostics.[12]
In 2021, SRL Diagnostics acquired the remaining stake in its Kerala-based joint venture, DDRC, for ₹350 crore. With the addition of DDRC's 220 labs to its lab network, SRL became the biggest pathology lab chain in India with a total of 430 labs.[13]
In 2023, SRL Diagnostics changed its name to Agilus Diagnostics.[14]
Operations
[edit] | This section may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (November 2018) |
Agilus has two reference labs one in Goregaon (Mumbai), and one in Gurgaon (Haryana), India. The company has more than 418 networking laboratories,[15] including four "Centers of Excellence", 26 radiology/imaging centers, 40 NABL accredited, and four CAP-accredited labs and a footprint spanning over 9000 collection points in India.[16] Along with this, the company also has large labs in Dubai, Sri Lanka and Nepal, and about 70 different collection points in various countries outside India.[17]
Agilus Diagnostics claims to offer more than 3,500 different tests in pathology, radiology, wellness, occupational health and clinical trials and also carries out more than 107,000 tests in a day.[18] Agilus Diagnostics operates diagnostic centres, collection centres, and laboratories. Agilus Diagnostics also offers tests in pathology covering biochemistry, immunology, herpetology, clinical pathology, histopathology and immunohistochemistry, microbiology, molecular biology, cytogenetics, and flow cytometry.[19]
References
[edit]- ^ Unnikrishnan, C. H. (22 August 2008). "SRL Ranbaxy mulls merger with Fortis Health". Mint. Retrieved 9 January 2023.
- ^ V, Narayanan (9 June 2022). "SRL Diagnostics to set up central reference lab in Chennai". The Hindu Businessline. Retrieved 9 January 2023.
- ^ a b "SRL Limited". CRISIL. Retrieved 6 January 2023.
- ^ "Agilus Diagnostics withdraws IPO plans, says SEBI". Moneycontrol. 22 February 2024. Retrieved 23 February 2024.
- ^ "Ranbaxy, Specialty Lab Unit To Be Opened Today". Business Standard. Retrieved 29 November 2024.
- ^ Kandhari, Ruhi (7 May 2019). "Can IHH help SRL finally scratch its 10-year itch?". The Ken. Retrieved 9 January 2023.
- ^ D'Silva, Jeetha. "SRL Ranbaxy plans to set up four more labs". The Economic Times. Retrieved 9 January 2023.
- ^ "Specialty, Ranbaxy to call it a day". The Times of India. 25 July 2001. Retrieved 29 November 2024.
- ^ "SRL Ranbaxy rechristened as Super Religare Lab". mint. 29 September 2008. Retrieved 9 January 2023.
- ^ "Piramal Healthcare completes sale of diagnostics arm to SRL". Business Standard India. 21 August 2010. Retrieved 9 January 2023.
- ^ "Fortis completes acquisition of 74.59% stake in SRL". Business Standard India. 12 May 2011. Retrieved 9 January 2023.
- ^ Vijayraghavan, Kala. "Super Religare Laboratories rechristens itself as 'SRL Diagnostics'; launches new logo". The Economic Times. Retrieved 9 January 2023.
- ^ Jayan, T. V. (30 March 2021). "SRL becomes India's largest pathlab chain after acquiring DDRC". The Hindu Businessline. Retrieved 9 January 2023.
- ^ Pilla, Viswanath (2023-05-27). "SRL Diagnostics rebrands as Agilus Diagnostics". The Economic Times. ISSN 0013-0389. Retrieved 2023-12-09.
- ^ "Agilus Diagnostics".
- ^ "According to Ibef.org".
- ^ "Microsoft News".
- ^ "According to IBEF".
- ^ "Bloomberg". Bloomberg News.